LONDON, England—Investigators for the REPRISE III trial testing the Lotus transcatheter valve system (Boston Scientific) have taken a closer look at two of the outlier findings that generated much of ...
NEW HOPE, Pa., March 06, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to ...
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
Cardiac implantable electronic devices (CIEDs) constitute a major breakthrough in the management of heart rhythm disorders. These devices largely include bradycardia pacemakers, biventricular ...
Pacemakers and defibrillators will be the topic of the day when the NorthBay Cardiac Education Series offers its quarterly presentation next week. Dominic Uchikuru, territory manager for St. Jude ...
Clinical study evaluated impact of AVIM therapy as compared to standard pacing using invasive pressure-volume loop analysis in 16 hypertensive pacemaker-indicated patients Results demonstrate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results